Atıf İçin Kopyala
Ricke J., Schinner R., Seidensticker M., Gasbarrini A., van Delden O. M., Amthauer H., ...Daha Fazla
JOURNAL OF HEPATOLOGY, cilt.75, sa.6, ss.1387-1396, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
75
Sayı:
6
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1016/j.jhep.2021.07.037
-
Dergi Adı:
JOURNAL OF HEPATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.1387-1396
-
Anahtar Kelimeler:
ALBI score, Hepatocellular carcinoma, Radioembolization, Selective internal radiation therapy, Sorafenib, RADIOEMBOLIZATION, DISEASE, PREVENTION, Y-90
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
Background & Aims: SORAMIC is a previously published randomised controlled trial assessing survival in patients with advanced hepatocellular carcinoma who received sorafenib with or without selective internal radiation therapy (SIRT). Based on the per-protocol (PP) population, we assessed whether the outcome of patients receiving SIRT+sorafenib vs. sorafenib alone was affected by adverse effects of SIRT on liver function.